Replies to post #673 on Clinical Data (CLDA)

[Fourthquarter]

At this rate the price will be around $30 by this Friday IMHO...question is when all shorts are starting to cover???That is when the real fun begins here....IMHO
GLTA

[pcrutch]

As I explain in the article, the different bear ideas are mostly unfounded. It's just more crap out of TheStreet.com.

Viibryd has the potential to be a blockbuster drug very easily in the hands of a big firm. Estimates of $1b in sales are conservative in my opinion. People wont always take the cheapest option, especially if that means having sexual dysfunction.